Analysis of risk factors affecting the prognosis of pancreatic neuroendocrine tumors.
- Author:
Ming TAO
1
;
Chunhui YUAN
1
;
Dianrong XIU
2
;
Xueying SHI
3
;
Liyuan TAO
4
;
Zhaolai MA
1
;
Bin JIANG
1
;
Zhipeng ZHANG
1
;
Lingfu ZHANG
1
;
Hangyan WANG
1
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; diagnosis; pathology; Neoplasm Staging; Neuroendocrine Tumors; diagnosis; pathology; Pancreatic Neoplasms; diagnosis; pathology; Risk Factors; Young Adult
- From: Chinese Medical Journal 2014;127(16):2924-2928
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDPancreatic neuroendocrine tumors (pNETs) are a type of tumors with the characteristics of easy metastasis and recurrence. Till date, the risk factors affecting the prognosis are still in the debate. In this study, several risk factors will be discussed combined with our cases and experience.
METHODSThirty-three patients diagnosed as pNETs were enrolled and the clinical features, blood tests, pathological features, surgical treatment, and follow-up data of these patients were collected and analyzed.
RESULTSIn this study, operation time of G3 cases was longer than G1/G2 cases (P = 0.017). The elevated level of tumor markers such as AFP, CEA, Ca125, and Ca19-9 may predict easier metastasis, earlier recurrence, and poor prognosis (P = 0.007). The presence of cancer embolus and nerve invasion increases along with the TNM stage (P = 0.037 and P = 0.040), and the incidence of positive surgical margin increased (P = 0.007). When the presence of nerve invasion occurs, the chance of cancer embolus and lymph node metastasis also increases (P = 0.016 and P = 0.026).
CONCLUSIONSpNETs were tumors with the features of easy recurrence and metastasis and many risk factors could affect its prognosis such as the elevated levels of tumor markers and the presence of nerve invasion, except some recognized risk factors. If one or more of these factors existed, postoperative treatments may be needed to improve prognosis.